Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lipinski

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Hematology (Amsterdam, Netherlands)|August 15, 2012
Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of ironB Lipinski, E Pretorius
Medical Hypotheses|December 1, 1991
Significance of fibrin formation and dissolution in the pathogenesis and treatment of cancerL G Egyud, B Lipinski
Thrombosis and Haemostasis|March 1, 1997
Ticlopidine may reduce functional fibrinogen levels by inhibition of MPC incorporation into fibrinB Lipinski, A S Krolewski
Diabetologia|July 1, 1997
Macromolecular protein complex in human plasma may explain altered fibrin gel structure in IDDM patientsB Lipinski, A S Krolewski
Medical Hypotheses|April 28, 2000
Resistance of cancer cells to immune recognition and killingB Lipinski, L G Egyud
Blood|February 1, 1976
A study of the large heparin requirements in the generalized Shwartzman reactionV Gurewich, B Lipinski, R Wetmore
Diabetologia|November 3, 2001
Is the macromolecular protein complex (MPC) a marker for oxidative stress in diabetes mellitus?B Lipinski, I Lipinska, Y Kato
Thrombosis and Haemostasis|December 31, 1976
The effect of the fibrinogen concentration and the leukocyte count on intravascular fibrin deposition from soluble fibrin monomer complexesV Gurewich, B Lipinski, E Hyde
Thrombosis and Haemostasis|December 31, 1976
Thrombin elaboration in endotoxin-induced intravascular fibrin deposition. A leukocyte dependent process distinct from systemic hypercoagulabilityB Lipinski, V Gurewich, E Hyde
Thrombosis Research|June 1, 1974
Letter: The fibrinogenolytic pathway of fibrinogen catabolism: additional commentsB Lipinski, I Lipinska, V Gurewich
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Hematology (Amsterdam, Netherlands)|August 15, 2012
Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of ironB Lipinski, E Pretorius
Medical Hypotheses|December 1, 1991
Significance of fibrin formation and dissolution in the pathogenesis and treatment of cancerL G Egyud, B Lipinski
Thrombosis and Haemostasis|March 1, 1997
Ticlopidine may reduce functional fibrinogen levels by inhibition of MPC incorporation into fibrinB Lipinski, A S Krolewski
Diabetologia|July 1, 1997
Macromolecular protein complex in human plasma may explain altered fibrin gel structure in IDDM patientsB Lipinski, A S Krolewski
Medical Hypotheses|April 28, 2000
Resistance of cancer cells to immune recognition and killingB Lipinski, L G Egyud
Blood|February 1, 1976
A study of the large heparin requirements in the generalized Shwartzman reactionV Gurewich, B Lipinski, R Wetmore
Diabetologia|November 3, 2001
Is the macromolecular protein complex (MPC) a marker for oxidative stress in diabetes mellitus?B Lipinski, I Lipinska, Y Kato
Thrombosis and Haemostasis|December 31, 1976
The effect of the fibrinogen concentration and the leukocyte count on intravascular fibrin deposition from soluble fibrin monomer complexesV Gurewich, B Lipinski, E Hyde
Thrombosis and Haemostasis|December 31, 1976
Thrombin elaboration in endotoxin-induced intravascular fibrin deposition. A leukocyte dependent process distinct from systemic hypercoagulabilityB Lipinski, V Gurewich, E Hyde
Thrombosis Research|June 1, 1974
Letter: The fibrinogenolytic pathway of fibrinogen catabolism: additional commentsB Lipinski, I Lipinska, V Gurewich
Pageof 6